Document is current
Any future updates will be listed below
-
Authors
van Winkel, Suzanne L. https://orcid.org/0000-0001-7273-4386
Samperna, Riccardo
Loehrer, Elizabeth A.
Drukker, Caroline A.
Sessink, Kelly
Karssemeijer, Nico
Mann, Ritse M.
-
Funding
Funding for this research was provided by:
the European Union – operational program East (EFRO – OP Oost).
- License Information
-
More Information
Article History
Received: 20 November 2024
Revised: 24 March 2025
Accepted: 26 April 2025
First Online: 12 June 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Ritse M. Mann, MD, PhD.
: The authors of this manuscript declare relationships with the following companies: N.K.: CSO ScreenPoint Medical, shareholder of Volpara. R.M.: Shares a collaborative European funding in which ScreenPoint Medical is a partner, is part of the Medical Advisory Board of ScreenPoint Medical, has grants/grants pending with Bayer Healthcare, Siemens Healthineers, Medtronic, BD, Koning, and Seno Medical. R.M. is a member of the Advisory Editorial Board of European Radiology (European Society of Breast Imaging) and, as such, has not participated in the selection or review processes for this article. The remaining authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary for this paper. Suzanne L. van Winkel, RN, MSc (first author) and Elizabeth A. Loehrer, PhD, are clinical epidemiologists. Both authors have completed advanced master’s-level training in epidemiology, including statistics and biometry. Elizabeth A. Loehrer has already gained substantial experience in this field and kindly provided advice when appropriate or required.
: Written informed consent was waived by the Institutional Review Board due to the large-scale retrospective nature of the research and because it was classified as Non-WMO research under Dutch law (Medical Research Involving Human Subjects Act). Active objection in the electronic patient record (EPR) against anonymous data reuse for research was an exclusion criterion.
: Institutional Review Board approval was not required because this retrospective observational study was classified as Non-WMO research under Dutch law (Medical Research Involving Human Subjects Act). The study adhered to national privacy protection guidelines and was registered by the ethical committee (CMO registration number 2020-6325).
: There is no overlap with other study subjects or cohorts. However, some of our research projects with very different purposes and information extraction may involve some overlap in the cohort, though this does not include any published articles.
:
